Assesses adults 19–64 years of age who have schizophrenia and were dispensed and remained on an antipsychotic medication for at least 80% of their treatment period.
Why It Matters
Schizophrenia is a chronic and disabling psychiatric disorder that requires ongoing treatment and monitoring. Symptoms include hallucinations, illogical thinking, memory impairment and incoherent speech.1 Medication nonadherence is common and a major concern in the treatment of schizophrenia. Using antipsychotic medications as prescribed reduces the risk of relapse or hospitalization.2
Results
| ADHERENCE TO ANTIPSYCHOTIC MEDICATIONS FOR INDIVIDUALS WITH SCHIZOPHRENIA | |||||
|---|---|---|---|---|---|
| Commercial | Medicaid | Medicare | |||
| Year | HMO | PPO | HMO | HMO | PPO |
| 2017 | — | — | 59.1 | — | — |
| 2016 | — | — | 59.2 | — | — |
| 2015 | — | — | 58.0 | — | — |
| 2014 | — | — | 60.1 | — | — |
| 2013 | — | — | 60.1 | — | — |
References
- American Psychiatric Association. Schizophrenia Fact Sheet. http://www.dsm5.org/Documents/Schizophrenia%20Fact%20Sheet.pdf.
- Busch, A.B., A.F. Lehman, H. Goldman, & R.G. Frank. 2009. “Changes over time and disparities in schizophrenia treatment quality.” Med Care 47(2), 199–207.